Paper41247262
Xuetongsu attenuates bone destruction in rheumatoid arthritis by suppressing RANKL/RANK/NFATc1 pathway to inhibit osteoclastogenesis and bone resorption.
Zheng H and 11 others. Bone Joint Res, 2025. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Xuetongsu attenuates bone destruction in rheumatoid arthritis by suppressing RANKL/RANK/NFATc1 pathway to inhibit osteoclastogenesis and bone resorption. Papers, record 41247262. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41247262
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Xuetongsu attenuates bone destruction in rheumatoid arthritis by suppressing RANKL/RANK/NFATc1 pathway to inhibit osteoclastogenesis and bone resorption.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39237134 | Generation of cytotoxic aptamers specifically targeting fibroblast-like synoviocytes by CSCT-SELEX for treatment of rheumatoid arthritis. | Ann Rheum Dis | 2025 | https://conductscience.org/library/papers/39237134 | PubMed |
| 2 | 33091494 | Kadsura heteroclita stem ethanol extract protects against carbon tetrachloride-induced liver injury in mice via suppression of oxidative stress, inflammation, and apoptosis. | J Ethnopharmacol | 2021 | https://conductscience.org/library/papers/33091494 | PubMed |
| 3 | 37907083 | Melatonin induces RAW264.7 cell apoptosis via the BMAL1/ROS/MAPK-p38 pathway to improve postmenopausal osteoporosis. | Bone Joint Res | 2023 | https://conductscience.org/library/papers/37907083 | PubMed |
| 4 | 32039154 | Xuetonglactones A-F: Highly Oxidized Lanostane and Cycloartane Triterpenoids From Kadsura heteroclita Roxb. Craib. | Front Chem | 2019 | https://conductscience.org/library/papers/32039154 | PubMed |
| 5 | 17935853 | Biochemical properties and regulation of cathepsin K activity. | Biochimie | 2008 | https://conductscience.org/library/papers/17935853 | PubMed |
| 6 | 35705856 | Mechanisms of joint destruction in rheumatoid arthritis - immune cell-fibroblast-bone interactions. | Nat Rev Rheumatol | 2022 | https://conductscience.org/library/papers/35705856 | PubMed |
| 7 | 28228278 | Immunopathogenesis of Rheumatoid Arthritis. | Immunity | 2017 | https://conductscience.org/library/papers/28228278 | PubMed |
| 8 | 29417936 | Rheumatoid arthritis. | Nat Rev Dis Primers | 2018 | https://conductscience.org/library/papers/29417936 | PubMed |
| 9 | 38340949 | Xuetongsu attenuates bone destruction in collagen-induced arthritis mice by inhibiting osteoclast differentiation and promoting osteoclast apoptosis. | Int J Biochem Cell Biol | 2024 | https://conductscience.org/library/papers/38340949 | PubMed |
| 10 | 39211448 | Research progress of ultrasound in accurate evaluation of cartilage injury in osteoarthritis. | Front Endocrinol (Lausanne) | 2024 | https://conductscience.org/library/papers/39211448 | PubMed |
| 11 | 12391400 | Guidelines for the design and statistical analysis of experiments using laboratory animals. | ILAR J | 2002 | https://conductscience.org/library/papers/12391400 | PubMed |
| 12 | 32024800 | Osteoclast-mediated bone resorption is controlled by a compensatory network of secreted and membrane-tethered metalloproteinases. | Sci Transl Med | 2020 | https://conductscience.org/library/papers/32024800 | PubMed |
| 13 | 27166176 | PTPN22 polymorphisms, but not R620W, were associated with the genetic susceptibility of systemic lupus erythematosus and rheumatoid arthritis in a Chinese Han population. | Hum Immunol | 2016 | https://conductscience.org/library/papers/27166176 | PubMed |
| 14 | 12438440 | Osteoclasts are essential for TNF-alpha-mediated joint destruction. | J Clin Invest | 2002 | https://conductscience.org/library/papers/12438440 | PubMed |
| 15 | 39090667 | Suppression of NUPR1 in fibroblast-like synoviocytes reduces synovial fibrosis via the Smad3 pathway. | J Transl Med | 2024 | https://conductscience.org/library/papers/39090667 | PubMed |
| 16 | 26320409 | Complexity of cancer protease biology: Cathepsin K expression and function in cancer progression. | Semin Cancer Biol | 2015 | https://conductscience.org/library/papers/26320409 | PubMed |
| 17 | 38810118 | Engineering Efferocytosis-Mimicking Nanovesicles to Regulate Joint Anti-Inflammation and Peripheral Immunosuppression for Rheumatoid Arthritis Therapy. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/38810118 | PubMed |
| 18 | 37732818 | Appraising causal risk and protective factors for rheumatoid arthritis. | Bone Joint Res | 2023 | https://conductscience.org/library/papers/37732818 | PubMed |
| 19 | 31119697 | Probiotics and bone disorders: the role of RANKL/RANK/OPG pathway. | Aging Clin Exp Res | 2020 | https://conductscience.org/library/papers/31119697 | PubMed |
| 20 | 39220257 | Targeting Parkin-regulated metabolomic change in cartilage in the treatment of osteoarthritis. | iScience | 2024 | https://conductscience.org/library/papers/39220257 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42955510 | Capsanthin at the crossroads of arthritis: from molecular mechanisms to therapeutic avenues. | Inflammopharmacology | 2026 | https://conductscience.org/library/papers/42955510 | PubMed |
| 42899200 | Mitochondrial Metabolic Reprogramming in Macrophages: A Key Driver of Rheumatoid Arthritis. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/42899200 | PubMed |
| 42898959 | Targeting pathogenic immune cells in rheumatoid arthritis: emerging immunotherapeutic frontiers. | Front Immunol | 2026 | https://conductscience.org/library/papers/42898959 | PubMed |
| 42883322 | Polydeoxyribonucleotide Promotes Longitudinal Bone Growth Through the Hepatic JAK2-STAT5/IGF-1 Axis Involving A2A Receptor Signaling. | Molecules | 2026 | https://conductscience.org/library/papers/42883322 | PubMed |
| 42840579 | Neuro-immune-bone axis in post-traumatic bone regeneration: temporal regulation, dysregulation mechanisms, and therapeutic implications. | Front Immunol | 2026 | https://conductscience.org/library/papers/42840579 | PubMed |
| 42656057 | Plant-Derived Heterocyclic Compounds: A Promising Review on Natural Remedies for Rheumatoid Arthritis Management and Their Mechanistic Insights in Inflammation and Joint Protection. | Basic Clin Pharmacol Toxicol | 2026 | https://conductscience.org/library/papers/42656057 | PubMed |
| 42653732 | Etoricoxib-Betamethasone Combination Attenuates Inflammatory Nociception and Edema in Adjuvant-Induced Arthritis via Cytokine and Macrophage Axis Modulation. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42653732 | PubMed |
| 42597291 | Sepsis in Autoimmune Rheumatic Diseases: Risk Factors, Pathophysiology, and Outcomes. | Risk Manag Healthc Policy | 2026 | https://conductscience.org/library/papers/42597291 | PubMed |
| 42525317 | Rutin as a multi-target anti-inflammatory phytochemical in arthritic disorders: pharmacological mechanisms and therapeutic potential. | Inflammopharmacology | 2026 | https://conductscience.org/library/papers/42525317 | PubMed |
| 42510437 | Comparative Efficacy and Safety of Intra-Articular Adipose-Derived, Bone Marrow-Derived, and Peripheral Blood-Derived Stem Cell Injections for Knee Osteoarthritis: A Systematic Review. | Bioengineering (Basel) | 2026 | https://conductscience.org/library/papers/42510437 | PubMed |
| 42488104 | Global burden of pain in malignant bone tumors: a meta-analysis of severity and health outcomes. | Front Oncol | 2026 | https://conductscience.org/library/papers/42488104 | PubMed |
| 42450753 | Promoting Bone Health in Layer Chickens from the Perspective of Mitochondrial Energy Metabolism in Osteoclasts. | Animals (Basel) | 2026 | https://conductscience.org/library/papers/42450753 | PubMed |
| 42433609 | Bioinspired 0D mitochondrial bioenergetic actuators rewire cartilage progenitor cell metabolism for osteoarthritis remission. | Bioact Mater | 2026 | https://conductscience.org/library/papers/42433609 | PubMed |
| 42221357 | Apigenin Upregulates Regulatory B Cells, Suppresses Class Switch Recombination, and Restores Immune Homeostasis to Treat Autoimmune Arthritis and Sepsis. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/42221357 | PubMed |
| 41910732 | Immunopharmacological effects of shikonin in experimental rheumatoid arthritis: a systematic review and meta-analysis of in vivo studies. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/41910732 | PubMed |
| 41781784 | Integrated LC-Orbitrap-MS and network pharmacology decipher the pharmacological basis of Eucommiae folium in treating rheumatoid arthritis. | Mol Divers | 2026 | https://conductscience.org/library/papers/41781784 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41247262
GET https://conductscience.org/api/papers/v1/41247262/references?page=2